文献速递泌尿男性生殖肿瘤

膀胱癌生存:女性长期预后更佳

Bladder cancer survival: Women better off in the long run.
PubMed 文献 · Eur J Cancer · 2018-04-07

基于挪威癌症登记处1997–2011年15129例膀胱尿路上皮癌新发病例,采用灵活参数相对生存模型分析性别特异性超额死亡风险比。结果显示女性在诊断后2年内风险显著高于男性,尤其肌层浸润性癌,此后男性风险更高;女性不良T分期分布解释了诊断后2年不利生存差异的一半。

要点

  • 女性膀胱癌患者诊断后2年内超额死亡风险显著高于男性,尤其肌层浸润性癌。
  • 诊断2年后男性超额死亡风险反而高于女性。
  • 女性不良T分期分布可解释诊断后2年不利生存差异的一半。

核心结论

  • 女性膀胱癌预后更差的常见观点需修正,挪威女性仅诊断后2年内预后较差,尤其肌层浸润性肿瘤。

研究设计与样本

  • 基于挪威癌症登记处1997–2011年15129例组织学证实的膀胱尿路上皮癌(浸润性和非浸润性)新发病例。
  • 采用灵活参数相对生存模型计算性别特异性超额死亡风险率和风险比,调整T分期和年龄,允许性别效应随时间变化。

主要发现

  • 诊断后2年内女性风险率显著高于男性,尤其肌层浸润性癌。
  • 诊断2年后男性风险率似乎更高。
  • 女性不良T分期分布解释了诊断后2年不利生存差异的一半。

关键数值与推荐

  • 女性诊断后2年内超额死亡风险显著高于男性,尤其肌层浸润性癌。
  • 诊断2年后男性风险率似乎更高。
  • 女性不良T分期分布解释诊断后2年不利生存差异的一半。

临床怎么用

  • 临床应关注女性膀胱癌患者诊断后2年内的高死亡风险,尤其肌层浸润性癌。
  • 长期随访中需注意男性患者诊断2年后风险可能更高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: Mortality among patients with bladder cancer is usually reported to be higher for women than men, but how the risk differs and why remain largely unexplained. We also described gender-specific differences in survival for patients with bladder cancer and estimated to what extent they can be explained by differences in T-stage distribution at the first diagnosis. METHODS: The present study comprised all 15,129 new cases of histologically verified invasive and non-invasive urothelial carcinoma of the urinary bladder diagnosed between 1997 and 2011 as registered in the Cancer Registry of Norway. Gender-specific excess mortality risk rates and risk ratios were calculated based on a flexible parametric relative survival model adjusting for T-stage and age, allowing the effect of gender to vary over time. We also present gender-specific relative survival curves for different T-stage patterns adjusted for age. RESULTS: Risk rates were significantly higher for women than men up to 2 years after bladder cancer diagnosis, particularly for muscle-invasive cancers. Thereafter, risk rates appeared to be higher in men. Adverse T-Stage distribution in women explained half of the unfavourable survival difference in female patients 2 years after diagnosis. CONCLUSION: The common view of worse bladder cancer prognosis in women than in men needs to be revised. Norwegian women have a less favourable prognosis solely within the first 2 years after diagnosis, particularly when diagnosed with a muscle-invasive tumour; parts of this discrepancy can be attributed to more severe initial diagnoses in women.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Andreassen BK, Grimsrud TK, Haug ES, et al. Bladder cancer survival: Women better off in the long run. Eur J Cancer. 2018. PMID: 29635144. doi:10.1016/j.ejca.2018.03.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。